Tyra Biosciences, Inc.
TYRAFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Tyra Biosciences, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 1, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Chung Wu Investment Group, LLC | 2026-03-31 | 2,000 | $76.6K | SEC filing |
| Sio Capital Management, LLC | 2026-03-31 | 605,439 | $23.2M | SEC filing |
| Commodore Capital LP | 2026-03-31 | 2,475,000 | $94.8M | SEC filing |
| ALLIANCEBERNSTEIN L.P. | 2026-03-31 | 31,990 | Not shown | SEC filing |
| AMERIPRISE FINANCIAL INC | 2026-03-31 | 144,900 | $5.55M | SEC filing |
| DIMENSIONAL FUND ADVISORS LP | 2026-03-31 | 91,826 | $3.52M | SEC filing |
| AQR CAPITAL MANAGEMENT LLC | 2026-03-31 | 29,423 | $1.13M | SEC filing |
| JANE STREET GROUP, LLC | 2026-03-31 | 10,169 | $389K | SEC filing |
| WELLINGTON MANAGEMENT GROUP LLP | 2026-03-31 | 77,169 | $2.96M | SEC filing |
| STATE STREET CORP | 2026-03-31 | 1,216,078 | $46.6M | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 190,039 | $7.28M | SEC filing |
| Tower Research Capital LLC (TRC) | 2026-03-31 | 3,005 | $115K | SEC filing |
| RHUMBLINE ADVISERS | 2026-03-31 | 39,660 | $1.52M | SEC filing |
| Point72 Asset Management, L.P. | 2026-03-31 | 38,850 | $1.49M | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 658,482 | $25.2M | SEC filing |
| DEUTSCHE BANK AG\ | 2026-03-31 | 20,495 | $785K | SEC filing |
| Rafferty Asset Management, LLC | 2026-03-31 | 34,856 | $1.33M | SEC filing |
| TWIN PEAKS WEALTH ADVISORS, LLC | 2026-03-31 | 7 | $268 | SEC filing |
| Balyasny Asset Management L.P. | 2026-03-31 | 351,479 | $13.5M | SEC filing |
| JPMORGAN CHASE & CO | 2026-03-31 | 66,789 | $2.31M | SEC filing |
- Each value is checked against Tyra Biosciences, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the value per share could not be confirmed against the share prices on file from within three months of the report date.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Tyra Biosciences, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-11-21 · MORE ROBERT J: Larger than all 113 other insider sales of Common Stock on file. SEC filing
- 2025-11-19 · Bensen Daniel: Larger than 106 of the 113 other insider sales of Common Stock on file. SEC filing
- 2025-11-18 · Bensen Daniel: Larger than 109 of the 113 other insider sales of Common Stock on file. SEC filing
- 2025-11-14 · Bensen Daniel: Larger than 112 of the 113 other insider sales of Common Stock on file. SEC filing
- 2025-06-12 · KAPLAN GILLA: Larger than 103 of the 113 other insider sales of Common Stock on file. SEC filing
- 2024-11-06 · Kjellson Nina S: Larger than 105 of the 113 other insider sales of Common Stock on file. SEC filing
- 2024-10-31 · Kjellson Nina S: Larger than 111 of the 113 other insider sales of Common Stock on file. SEC filing
- 2024-10-18 · Harris Todd: Larger than 104 of the 113 other insider sales of Common Stock on file. SEC filing
- 2024-10-16 · Harris Todd: Larger than 102 of the 113 other insider sales of Common Stock on file. SEC filing
- 2024-02-02 · Harris Todd: Larger than 110 of the 113 other insider sales of Common Stock on file. SEC filing
- 2024-02-02 · Bensen Daniel: Larger than 108 of the 113 other insider sales of Common Stock on file. SEC filing
- 2023-06-16 · Harris Todd: Larger than 107 of the 113 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-25 | KAPLAN GILLA · Director | Common Stock | S — Open market or private sale | −14,295 | 36.97 | SEC filing |
| 2026-02-12 | Bensen Daniel · Chief Discovery Officer | Common Stock | S — Open market or private sale | −2,128 | 31.50 | SEC filing |
| 2026-02-12 | Bensen Daniel · Chief Discovery Officer | Common Stock | S — Open market or private sale | −5,872 | 33.37 | SEC filing |
| 2026-01-12 | Bensen Daniel · Chief Discovery Officer | Common Stock | S — Open market or private sale | −6,983 | 28.44 | SEC filing |
| 2026-01-12 | Bensen Daniel · Chief Discovery Officer | Common Stock | S — Open market or private sale | −1,017 | 29.08 | SEC filing |
| 2025-12-19 | MORE ROBERT J · Director | Common Stock | S — Open market or private sale | −10,000 | 25.00 | SEC filing |
| 2025-12-12 | Bensen Daniel · Chief Discovery Officer | Common Stock | S — Open market or private sale | −8,000 | 22.64 | SEC filing |
| 2025-11-21 | MORE ROBERT J · Director | Common Stock | S — Open market or private sale | −246,871 | 20.25 | SEC filing |
Showing 8 of 18 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-28 | MORE ROBERT J · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +13,160 | SEC filing |
| 2026-05-28 | Verjee Rehan · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +13,160 | SEC filing |
| 2026-05-28 | Simson Jake · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +13,160 | SEC filing |
| 2026-05-28 | Rothenberg Stephen Michael · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +13,160 | SEC filing |
| 2026-05-28 | Moran Susan · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +13,160 | SEC filing |
| 2026-05-28 | Gulfo Adele M. · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +13,160 | SEC filing |
| 2026-05-28 | RA Capital Healthcare Fund LP · Director, 10% owner | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +13,160 | SEC filing |
| 2026-05-05 | Fuhrman Alan · Chief Financial Officer | Common Stock | A — Grant, award, or other acquisition | +20,000 | SEC filing |
Showing 8 of 20 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-03-26 | KAPLAN GILLA · Director | Common Stock | D — Disposition to the issuer | −53,172 | SEC filing |
| 2024-10-18 | RA Capital Healthcare Fund LP · Director, 10% owner | Common Stock | J — Other acquisition or disposition | −1,000,000 | SEC filing |
| 2024-10-18 | Boxer Capital Management, LLC · Other | Common Stock | D — Disposition to the issuer | −2,000,000 | SEC filing |
| 2024-10-18 | RA Capital Healthcare Fund LP · Director, 10% owner | Pre-Funded Warrants (Right to Buy) | J — Other acquisition or disposition | +2,358,457 | SEC filing |
Showing 4 of 4 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.